Conference Coverage
Conference Coverage
Genetic screening for CLL premature, speaker says
Photo courtesy of the National Institute of General Medical Science NEW YORK—Research has shown that family history is a strong risk factor for...
Conference Coverage
Anticipate monoclonals in first-line therapy for multiple myeloma
Good results in relapsed and refractory multiple myeloma for combination therapy with daratumumab may mean monoclonal antibodies may soon have...
Conference Coverage
Few non-ICU patients receive palliative care consults
A significant percentage of patients who meet criteria for palliative care consultations do not receive a consult during their hospital stay,...
Conference Coverage
Surgical infections, early discharge hike readmissions in extrahepatic cholangiocarcinoma
WASHINGTON, DC
Conference Coverage
Biomarker identifies precancerous pancreatic cysts
LAS VEGAS - In fluid derived from pancreatic cysts, methylated DNA markers predict the presence of high-grade dysplasia or cancer, and could help...
Conference Coverage
No longer a hand-me-down approach to WM
NEW YORK—Whole-genome sequencing has changed the entire approach to drug development for Waldenström’s macroglobulinemia (WM), according to a...
Conference Coverage
Lung cancer screening found effective in a community hospital
Lung cancer screening with low-dose CT scans in a community hospital setting replicates results from international and multicenter trials when it...
Conference Coverage
Automated colonoscopy risk classification for veterans
LAS VEGAS
Conference Coverage
Speaker says use the best regimen ASAP in MM
NEW YORK—It’s important to use the best possible regimen as soon as possible when treating patients with multiple myeloma (MM), according to a...
Conference Coverage
‘Achilles heels’ open doors to myeloma advances
Three “Achilles heels” of multiple myeloma offer exciting promise for additional advances that will begin to see therapeutic payoffs within the...
Conference Coverage
Doc provides perspective on CAR T-cell therapy in CLL
Photo from Penn Medicine NEW YORK—Trial data on the use of chimeric antigen receptor (CAR) T cells in chronic lymphocytic leukemia (CLL) are...